Osteoporosis and calcium-regulating hormones. 1981

P Vigo, and E Corghi, and P Favini, and R Girardello, and S Ortolani, and E E Polli

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D002117 Calcitriol The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption. 1 alpha,25-Dihydroxycholecalciferol,1 alpha,25-Dihydroxyvitamin D3,1, 25-(OH)2D3,1,25(OH)2D3,1,25-Dihydroxycholecalciferol,1,25-Dihydroxyvitamin D3,1 alpha, 25-dihydroxy-20-epi-Vitamin D3,1,25(OH)2-20epi-D3,1,25-dihydroxy-20-epi-Vitamin D3,20-epi-1alpha,25-dihydroxycholecaliferol,Bocatriol,Calcijex,Calcitriol KyraMed,Calcitriol-Nefro,Decostriol,MC-1288,MC1288,Osteotriol,Renatriol,Rocaltrol,Silkis,Sitriol,Soltriol,Tirocal,1 alpha,25 Dihydroxyvitamin D3,1,25 Dihydroxycholecalciferol,1,25 Dihydroxyvitamin D3,1,25 dihydroxy 20 epi Vitamin D3,Calcitriol Nefro,D3, 1 alpha,25-Dihydroxyvitamin,D3, 1,25-Dihydroxyvitamin,D3, 1,25-dihydroxy-20-epi-Vitamin,KyraMed, Calcitriol,MC 1288
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

P Vigo, and E Corghi, and P Favini, and R Girardello, and S Ortolani, and E E Polli
October 1986, European journal of clinical investigation,
P Vigo, and E Corghi, and P Favini, and R Girardello, and S Ortolani, and E E Polli
July 1984, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
P Vigo, and E Corghi, and P Favini, and R Girardello, and S Ortolani, and E E Polli
June 1979, Endocrinologia japonica,
P Vigo, and E Corghi, and P Favini, and R Girardello, and S Ortolani, and E E Polli
March 1988, Nihon Seikeigeka Gakkai zasshi,
P Vigo, and E Corghi, and P Favini, and R Girardello, and S Ortolani, and E E Polli
May 1997, Alcoholism, clinical and experimental research,
P Vigo, and E Corghi, and P Favini, and R Girardello, and S Ortolani, and E E Polli
January 1991, Problemy endokrinologii,
P Vigo, and E Corghi, and P Favini, and R Girardello, and S Ortolani, and E E Polli
July 1986, Nihon Jinzo Gakkai shi,
P Vigo, and E Corghi, and P Favini, and R Girardello, and S Ortolani, and E E Polli
March 1984, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
P Vigo, and E Corghi, and P Favini, and R Girardello, and S Ortolani, and E E Polli
April 1988, Alcoholism, clinical and experimental research,
P Vigo, and E Corghi, and P Favini, and R Girardello, and S Ortolani, and E E Polli
November 1987, Kidney international,
Copied contents to your clipboard!